Effect of systemic monosodium glutamate (MSG) on headache and pericranial muscle sensitivity

L Baad-Hansen1, Be Cairns, M Ernberg

  • 1Department of Clinical Oral Physiology, School of Dentistry, University of Aarhus, Aarhus, Denmark. lbhansen@odont.au.dk

Insights

Monosodium glutamate (MSG) intake can trigger headaches and pericranial muscle tenderness in some individuals. This study found MSG increased headache reports and elevated systolic blood pressure, but not muscle pain.

Area of Science:

  • Neuroscience
  • Gastroenterology
  • Clinical Pharmacology

Background:

  • Monosodium glutamate (MSG) is a common food additive with a controversial history regarding its potential adverse effects.
  • Previous research suggests a link between MSG consumption and adverse reactions, including headaches, though mechanisms remain debated.

Purpose of the Study:

  • To investigate the effects of oral monosodium glutamate (MSG) administration on headache occurrence and pericranial muscle sensitivity.
  • To assess changes in pain thresholds, blood pressure, and heart rate following MSG intake.

Main Methods:

  • A double-blinded, placebo-controlled, crossover study involving 14 healthy male participants.
  • Participants consumed sugar-free soda containing either MSG (75 or 150 mg/kg) or a placebo (NaCl).
  • Assessed plasma glutamate levels, pain, pressure pain thresholds, blood pressure, heart rate, and adverse effects for 2 hours post-ingestion.

Main Results:

  • MSG consumption led to a significant increase in reported headaches and subjective pericranial muscle tenderness.
  • No significant muscle pain or changes in mechanical sensitivity were observed.
  • Systolic blood pressure was elevated in the high MSG dose session compared to low MSG and placebo sessions.

Conclusions:

  • Oral MSG administration can induce headaches and pericranial muscle tenderness in susceptible individuals.
  • MSG may influence cardiovascular parameters, indicated by elevated systolic blood pressure.
  • Findings contribute to understanding the pathophysiology of MSG-related headaches and craniofacial pain sensitivity.